Therapeutic targets and pharmacological mechanisms of Coptidis Rhizoma against ulcerative colitis: Findings of system pharmacology and bioinformatics analysis
机构:[1]Dongguan Hospital of Guangzhou University of Chinese Medicine, Dongguan, Guangdong, China.[2]The Second Clinical College of Guangzhou University of Chinese Medicine, Guangzhou, China.广东省中医院[3]State Key Laboratory of Dampness Syndrome of Chinese Medicine, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, China.广东省中医院[4]Guangdong-Hong Kong-Macau Joint Lab on Chinese Medicine and Immune Disease Research, Guangzhou, China.[5]Guangdong Provincial Key Laboratory of Clinical Research on Traditional Chinese Medicine Syndrome, Guangzhou, China.[6]Yang Chunbo Academic Experience Inheritance Studio of Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, China.广东省中医院
National Natural
Science Foundation of China (81274318). National Natural Science
Foundation of Guangdong (2021A1515011498). Key projects
supported by the National Natural Science Foundation of China
(U20A20397). The 2020 Guangdong Provincial Science and
Technology Innovation Strategy Special Fund (Guangdong-Hong
Kong-Macau Joint Lab, 2020B1212030006). Guangdong Provincial
key research and development program, (2020B1111100010).
Guangzhou Science and Technology Planning Project
(202201020288). Special Project of State Key Laboratory of
Dampness Syndrome of Chinese Medicine (SZ2021ZZ13,
SZ2021ZZ25, SZ2021ZZ44, SZ2021ZZ02).
第一作者机构:[1]Dongguan Hospital of Guangzhou University of Chinese Medicine, Dongguan, Guangdong, China.
共同第一作者:
通讯作者:
通讯机构:[1]Dongguan Hospital of Guangzhou University of Chinese Medicine, Dongguan, Guangdong, China.[3]State Key Laboratory of Dampness Syndrome of Chinese Medicine, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, China.[4]Guangdong-Hong Kong-Macau Joint Lab on Chinese Medicine and Immune Disease Research, Guangzhou, China.[5]Guangdong Provincial Key Laboratory of Clinical Research on Traditional Chinese Medicine Syndrome, Guangzhou, China.[6]Yang Chunbo Academic Experience Inheritance Studio of Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, China.
推荐引用方式(GB/T 7714):
Yang Yuanming,Hua Yiwei,Chen Weihuan,et al.Therapeutic targets and pharmacological mechanisms of Coptidis Rhizoma against ulcerative colitis: Findings of system pharmacology and bioinformatics analysis[J].FRONTIERS IN PHARMACOLOGY.2022,13:doi:10.3389/fphar.2022.1037856.
APA:
Yang Yuanming,Hua Yiwei,Chen Weihuan,Zheng Huan,Wu Haomeng...&Huang Shaogang.(2022).Therapeutic targets and pharmacological mechanisms of Coptidis Rhizoma against ulcerative colitis: Findings of system pharmacology and bioinformatics analysis.FRONTIERS IN PHARMACOLOGY,13,
MLA:
Yang Yuanming,et al."Therapeutic targets and pharmacological mechanisms of Coptidis Rhizoma against ulcerative colitis: Findings of system pharmacology and bioinformatics analysis".FRONTIERS IN PHARMACOLOGY 13.(2022)